➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
McKinsey

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Anecortave


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Anecortave?

Anecortave is an investigational drug.

There have been 33 clinical trials for Anecortave. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2003.

The most common disease conditions in clinical trials are Macular Degeneration, Glaucoma, and Glaucoma, Open-Angle. The leading clinical trial sponsors are Alcon Research, Manhattan Eye, Ear & Throat Hospital, and University of Iowa.

Recent Clinical Trials for Anecortave
TitleSponsorPhase
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant PatientsCornea Research Foundation of AmericaN/A
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular HypertensionAlcon ResearchPhase 2
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular HypertensionAlcon ResearchPhase 2/Phase 3

See all Anecortave clinical trials

Clinical Trial Summary for Anecortave

Top disease conditions for Anecortave
Top clinical trial sponsors for Anecortave

See all Anecortave clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
McKesson
Johnson and Johnson
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.